• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

物质使用障碍治疗结果:指标与标准的方法学概述

Substance Use Disorder Treatment Outcomes: Methodological Overview of Metrics and Criteria.

作者信息

Narváez-Camargo Marta, Lozano-Rojas Oscar, Mancheño-Velasco Cinta, Verdejo-García Antonio

机构信息

Department of Clinical and Experimental Psychology, University of Huelva, Huelva, Spain.

Research Centre of Natural Resources, Health and the Environment, University of Huelva, Huelva, Spain.

出版信息

Int J Methods Psychiatr Res. 2025 Jun;34(2):e70027. doi: 10.1002/mpr.70027.

DOI:10.1002/mpr.70027
PMID:40540529
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12180564/
Abstract

AIM

The heterogeneous metrics and criteria used to assess the effectiveness of substance use disorders treatment hinders cross-study comparisons. This review aims to parse such heterogeneity by analysing the operational definitions of variables used to derive metrics and outcome criteria, contributing to the standardisation process.

METHODS

We conducted a systematic review in PubMed and PsycINFO between January 2000 and October 2023. We included published studies on substance use disorders that featured at least one of seven 'a priori' defined variables commonly used to obtain metrics and criteria for treatment effectiveness. The review process and reporting followed Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines.

RESULTS

Were identified three areas that can be used to define metrics and criteria associated with treatment outcome: as 'substance use' (abstinence and relapses), 'treatment process' (readmission, dropout, retention, and adherence) and 'general wellbeing' (quality of life). Operational definitions and metrics and criteria used were overall inconsistent.

CONCLUSIONS

The establishment of guidelines for evaluation of treatment outcomes is imperative, as heterogeneity is still present in the literature. We recommend that future trials provide outcomes metrics relevant to the identified categories, and that standardisation efforts continue toward harmonised criteria to report and interpret those metrics.

摘要

目的

用于评估物质使用障碍治疗效果的异质性指标和标准阻碍了跨研究比较。本综述旨在通过分析用于得出指标和结果标准的变量的操作定义来剖析这种异质性,为标准化进程做出贡献。

方法

我们于2000年1月至2023年10月在PubMed和PsycINFO上进行了系统综述。我们纳入了关于物质使用障碍的已发表研究,这些研究至少包含七个“先验”定义变量中的一个,这些变量通常用于获取治疗效果的指标和标准。综述过程和报告遵循系统综述和Meta分析的首选报告项目(PRISMA)指南。

结果

确定了三个可用于定义与治疗结果相关的指标和标准的领域:“物质使用”(戒断和复发)、“治疗过程”(再次入院、辍学、留存率和依从性)以及“总体幸福感”(生活质量)。所使用的操作定义、指标和标准总体上不一致。

结论

由于文献中仍然存在异质性,因此制定治疗结果评估指南势在必行。我们建议未来的试验提供与已确定类别相关的结果指标,并且标准化工作应继续朝着统一标准的方向努力,以报告和解释这些指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c15/12180564/0afed2513bfb/MPR-34-e70027-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c15/12180564/9e698e68ae51/MPR-34-e70027-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c15/12180564/6c05f238e9ab/MPR-34-e70027-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c15/12180564/3e17b2e3216f/MPR-34-e70027-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c15/12180564/0afed2513bfb/MPR-34-e70027-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c15/12180564/9e698e68ae51/MPR-34-e70027-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c15/12180564/6c05f238e9ab/MPR-34-e70027-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c15/12180564/3e17b2e3216f/MPR-34-e70027-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c15/12180564/0afed2513bfb/MPR-34-e70027-g002.jpg

相似文献

1
Substance Use Disorder Treatment Outcomes: Methodological Overview of Metrics and Criteria.物质使用障碍治疗结果:指标与标准的方法学概述
Int J Methods Psychiatr Res. 2025 Jun;34(2):e70027. doi: 10.1002/mpr.70027.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Interventions to improve safe and effective medicines use by consumers: an overview of systematic reviews.改善消费者安全有效用药的干预措施:系统评价概述
Cochrane Database Syst Rev. 2014 Apr 29;2014(4):CD007768. doi: 10.1002/14651858.CD007768.pub3.
4
Healthcare outcomes assessed with observational study designs compared with those assessed in randomized trials.与随机试验中评估的医疗保健结果相比,观察性研究设计评估的医疗保健结果。
Cochrane Database Syst Rev. 2014 Apr 29;2014(4):MR000034. doi: 10.1002/14651858.MR000034.pub2.
5
Psychosocial interventions for cannabis use disorder.针对大麻使用障碍的心理社会干预措施。
Cochrane Database Syst Rev. 2016 May 5;2016(5):CD005336. doi: 10.1002/14651858.CD005336.pub4.
6
Psychosocial interventions for stimulant use disorder.兴奋剂使用障碍的心理社会干预。
Cochrane Database Syst Rev. 2024 Feb 15;2(2):CD011866. doi: 10.1002/14651858.CD011866.pub3.
7
Comparison of cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.纤维素、改性纤维素和合成膜在终末期肾病患者血液透析中的比较。
Cochrane Database Syst Rev. 2001(3):CD003234. doi: 10.1002/14651858.CD003234.
8
Psychological therapies for post-traumatic stress disorder and comorbid substance use disorder.创伤后应激障碍及共病物质使用障碍的心理治疗
Cochrane Database Syst Rev. 2016 Apr 4;4(4):CD010204. doi: 10.1002/14651858.CD010204.pub2.
9
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
10
Motivational interviewing for substance use reduction.动机性访谈减少物质使用。
Cochrane Database Syst Rev. 2023 Dec 12;12(12):CD008063. doi: 10.1002/14651858.CD008063.pub3.

本文引用的文献

1
Contextualising Experiences of Co-Occurring Mental Ill-Health and Substance Use Among Trans, Non-Binary, and Gender Diverse Young People: Implications for Tailored Harm Reduction Approaches.将跨性别、非二元性别和性别多样化年轻人中同时存在的心理健康问题和物质使用经历置于情境中:对量身定制的减少伤害方法的启示。
Community Ment Health J. 2025 Jan;61(1):181-192. doi: 10.1007/s10597-024-01342-y. Epub 2024 Sep 2.
2
Evaluating the Aspects of Quality of Life in Individuals with Substance Use Disorder: A Systematic Review Based on the WHOQOL Questionnaire.评估物质使用障碍患者的生活质量方面:基于世界卫生组织生活质量问卷的系统评价
J Multidiscip Healthc. 2023 Dec 28;16:4265-4278. doi: 10.2147/JMDH.S440764. eCollection 2023.
3
Feasibility and acceptability of a timeline follow-back method to assess opioid use, non-fatal overdose, and substance use disorder treatment.
评估阿片类药物使用、非致命性药物过量和物质使用障碍治疗的时间线回溯方法的可行性和可接受性。
Addict Behav. 2024 Jan;148:107873. doi: 10.1016/j.addbeh.2023.107873. Epub 2023 Sep 29.
4
Frontal tDCS reduces alcohol relapse rates by increasing connections from left dorsolateral prefrontal cortex to addiction networks.经颅直流电刺激减少前额叶背外侧皮层与成瘾网络的连接,从而降低酒精复发率。
Brain Stimul. 2023 Jul-Aug;16(4):1032-1040. doi: 10.1016/j.brs.2023.06.011. Epub 2023 Jun 20.
5
Does substance use disorder treatment completion reduce the risk of treatment readmission in Chile?物质使用障碍治疗完成是否会降低智利治疗再入院的风险?
Drug Alcohol Depend. 2023 Jul 1;248:109907. doi: 10.1016/j.drugalcdep.2023.109907. Epub 2023 Apr 29.
6
Agreement between self-reported illicit drug use and biological samples: a systematic review and meta-analysis.自我报告的非法药物使用与生物样本之间的一致性:系统评价和荟萃分析。
Addiction. 2023 Sep;118(9):1624-1648. doi: 10.1111/add.16200. Epub 2023 May 4.
7
Factors associated with problematic substance use before and during the COVID-19 pandemic among a drug addiction recovery cohort: A prospective study in the Netherlands, Belgium, and UK.在荷兰、比利时和英国,一项针对吸毒康复队列的前瞻性研究:COVID-19 大流行前后与问题性物质使用相关的因素。
J Subst Use Addict Treat. 2023 May;148:209025. doi: 10.1016/j.josat.2023.209025. Epub 2023 Mar 17.
8
Inpatients in substance use treatment with co-occurring psychiatric disorders: a prospective cohort study of characteristics and relapse predictors.物质使用障碍合并精神障碍住院患者:特征和复发预测因素的前瞻性队列研究。
BMC Psychiatry. 2023 Mar 9;23(1):152. doi: 10.1186/s12888-023-04632-z.
9
Predicting substance use disorder treatment follow-ups and relapse across the continuum of care at a single behavioral health center.在单一行为健康中心预测物质使用障碍治疗随访情况及整个照护连续过程中的复发情况。
J Subst Use Addict Treat. 2023 Apr;147:208933. doi: 10.1016/j.josat.2022.208933. Epub 2023 Jan 6.
10
Effects of Telehealth on Dropout and Retention in Care among Treatment-Seeking Individuals with Substance Use Disorder: A Retrospective Cohort Study.远程医疗对寻求治疗的物质使用障碍患者在治疗中辍学和保留的影响:一项回顾性队列研究。
Subst Use Misuse. 2023;58(4):481-490. doi: 10.1080/10826084.2023.2167496. Epub 2023 Jan 29.